A groundbreaking study led by researchers at McGill University and the Douglas Research Centre has unveiled specific cellular abnormalities in…
Read More

A groundbreaking study led by researchers at McGill University and the Douglas Research Centre has unveiled specific cellular abnormalities in…
Read More
The European Union (EU) has achieved a significant legislative milestone with the provisional agreement on the Critical Medicines Act (CMA),…
Read More
Bristol Myers Squibb (BMS) and Chinese biopharmaceutical giant Hengrui Pharma have announced a monumental licensing and collaboration agreement, potentially valued…
Read More
The US Food and Drug Administration (FDA) has unveiled its comprehensive final guidance for industry on collecting crucial post-marketing safety…
Read More
The field of statistical physics has reached a transformative milestone as researchers at the University of Würzburg, in collaboration with…
Read More
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
A groundbreaking study led by researchers at McGill University and the Douglas Research Centre has fundamentally altered the scientific understanding…
Read More
In a significant advancement for neurobiology and pain management, researchers from the University of Pennsylvania, Stanford University, and Carnegie Mellon…
Read More
In a discovery that fundamentally alters the scientific understanding of cellular metabolism, researchers at Stanford Medicine have identified that glucose,…
Read More